Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens
Script written by Atlantic Salmon Federation communications director Neville Crabbe. Podcast narrated by Charlie Schmidt and Caroline Losneck. Music by Ben Trout and Charlie Schmidt.
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
Genomic sequencing efforts are limited in developing countries, but scientists are mobilizing to help